Skip to main content
SpringerLink
Log in

Transkoronare Ablation der Septumhypertrophie (TASH): Ersetzt sie die Operation (Myektomie)?

  • BNK-Mitteilungen
  • Die Persönliche Meinung
  • Published:
Herz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bircks W, Schulte HD. Surgical treatment of hypertrophic obstructive cardiomyopathy with special reference to complications and to atypical hypertrophic obstructive cardiomyopathy. Eur Heart J 1983;4:Suppl F:187–90.

    PubMed  Google Scholar 

  2. Borggrefe M, Kuhn H, Königer HH, et al. Arrhythmias in hypertrophic obstructive and non obstructive cardiomyopathy. Eur Heart J 1983;4:Suppl F:245–51.

    PubMed  Google Scholar 

  3. Braunwald E. A new treatment for hypertrophic cardiomyopathy? Eur Heart J 1997;18:709–1.

    PubMed  CAS  Google Scholar 

  4. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998;98:2415–21.

    PubMed  CAS  Google Scholar 

  5. Franke A, Schöndube FA, Kühl HP, et al. Quantitative assessment of the operative results after extended myectomy and surgical reconstruction of the subvalvular mitral apparatus in hypertrophic obstructive cardiomyopathy, using dynamic three-dimensional transesophageal echocardiography. J Am Coll Cardiol 1998;31:1641–9.

    Article  Google Scholar 

  6. Gietzen FH, Kuhn HJ, Leuner CJ, et al. Transcoronary ablation of septum hypertrophy in hypertrophic obstructive cardiomyopathy: acute and long-term results in the elderly. Eur Heart J 1998;19:Supple:13. abstract.

    Google Scholar 

  7. Gietzen FH, Kuhn H, Leuner CJ, et al. Acute and long term results after transcoronary ablation of septum hypertrophy by selective septal branch injection of ethanol. A catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:Suppl 1:1–86 abstract.

    Google Scholar 

  8. Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long term results after transcoronary ablation of septal hypertrophy. Eur Heart J 1999;20:1342–54.

    Article  PubMed  CAS  Google Scholar 

  9. Gockel B, Gietzen F, Kuhn H. Dokumentation des unerwarteten plötzlichen Herztodes im zufällig abgeleiteten Langzeitelektrokardiogramm bei Patienten mit hypertrophischer obstructiver Kardiomyopathie. Z Kardiol 1995;84:Suppl 3:47.

    Google Scholar 

  10. Heric B, Lytle BW, Miller DP, et al. Surgical management of hypertrophic obstructive cardiomyopathy — early and late results. J Thorac Cardiovasc Surg 1995;110:195–208.

    Article  PubMed  CAS  Google Scholar 

  11. Kappenberger L, Linde C, Daubert C et al., and the PIC Study Group. Pacing in hypertrophic obstructive cardiomyopathy. A randomized cross over study. Eur Heart J 1997;18:1249–56.

    PubMed  CAS  Google Scholar 

  12. Kuhn H, Krelhaus W, Bircks W, et al. Indication for surgical treatment in patients with hypertrophic obstructive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ, eds. Cardiomyopathy and myocardial biopsy. Berlin-Heidelberg-New York: Springer, 1978:308–15.

    Google Scholar 

  13. Kuhn H, Gietzen F, Mercier J, et al. Studies of the clinical picture, course and prognosis of different forms of hypertrophic cardiomyopathy. Z Kardiol 1983;72:83–98.

    PubMed  CAS  Google Scholar 

  14. Kuhn H, Gietzen F, Leuner C, et al. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 1997;18:846–51.

    PubMed  CAS  Google Scholar 

  15. Kuhn H, Gietzen F, Schäfers M, et al. Changes of left ventricular outflow tract after transcoronary ablation of septum hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transesophageal echocardiography and measuring of myocardial glucose utilization and perfusion. Eur Heart J 1999;20:1808–17.

    Article  PubMed  CAS  Google Scholar 

  16. Kuhn H, Gietzen F, Jachmann E, et al. Die Bedeutung der Belastungsdopplerechokardiographie bei HOCM für die Behandlung mittels transkoronarer Ablation der Septum Hypertrophie (TASH). Z Kardiol 1999;88.1:Suppl:138. abstract

    Google Scholar 

  17. Kuhn H, Gietzen FH, Leuner CH, et al. Transcoronary ablation of septum hypertrophy (TASH): a new option of treatment for hypertrophic obstructive cardiomyopathy. Z Kardiol Suppl (in press).

  18. Kuhn H. Septal ablation in HOCM: Is there an arrhythmogenic potential? 11th World Symposium on Cardiac Pacing and Electrophysiology, Berlin 1999.

  19. Lösse B, Loogen F, Schulte HD. Hemodynamic long term results after medical and surgical therapy of hypertrophic cardiomyopathies. Z Kardiol 1987;76:Suppl 3:119–30.

    PubMed  Google Scholar 

  20. Maron BI, Epstein SE, Morrow AG. Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J 1983;4:Suppl F:175–85.

    PubMed  Google Scholar 

  21. Maron BI, Nishimura RA, Mc Kenna WJ, et al. Assessment of permanent dualchamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 1999:99:2927–33.

    PubMed  CAS  Google Scholar 

  22. Ommen SR, Nishimura RA, Squires RW, et al. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999;34:191–6.

    Article  PubMed  CAS  Google Scholar 

  23. Robbins RC, Stinson EB. Long term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996;111:586–94.

    Article  PubMed  CAS  Google Scholar 

  24. Schulte HD, Gramsch-Zabel H, Schwartzkopff B. Hypertrophic obstructive cardiomyopathy (HOCM): Surgical management. Schweiz Med Wochenschr 1995;125:1940–9.

    PubMed  CAS  Google Scholar 

  25. Schwartzkopff B, Stark P, Schulte HD, et al. Early changes in systolic and diastolic function at rest and exercise in patients with hypertrophic cardiomyopathy (HOCM) after myectomy. Z Kardiol 1997;86:438–49.

    Article  PubMed  CAS  Google Scholar 

  26. spirito P, Maron BI. Perspectives on the role of new treatment strategies in hypertrophic obstructive cardioymopathy. J Am Coll Cardiol 1999;33:1071–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik II-Schwerpunkt Kardiologie, Städtische Kliniken Bielefeld, Akademisches Lehrkrankenhaus der Universität Münster, Teutoburgerstraße 50, D-33604, Bielefeld

    Horst Kuhn & Frank Gietzen

Authors
  1. Horst Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank Gietzen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Horst Kuhn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuhn, H., Gietzen, F. Transkoronare Ablation der Septumhypertrophie (TASH): Ersetzt sie die Operation (Myektomie)?. Herz 24, 647–651 (1999). https://doi.org/10.1007/BF03044490

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03044490

Search

Navigation